![shutterstock_1873862197 [Converted]_edited.png](https://static.wixstatic.com/media/dfb6c4_dab9fb0cf76f487fa34b0ff1b6b266d1~mv2.png/v1/fill/w_353,h_200,al_c,q_85,usm_0.66_1.00_0.01,enc_auto/dfb6c4_dab9fb0cf76f487fa34b0ff1b6b266d1~mv2.png)
News
BioBuzz
11/25/20
Maryland Company Poised to Produce Millions of Point-of-Care COVID-19 Tests that Deliver Accurate Results in 15 minutes
NIH
09/02/20
The National Institutes of Health Award Maxim Biomedical Millions in Manufacturing and Scale Up Support for MaximBio SARS-CoV-2 Rapid Antigen Test
Cision
01/25/22
Maxim Biomedical Inc. Receives EUA for New ClearDetect™ COVID-19 Antigen Home Test
360Dx
10/19/20
Maxim Biomedical Ramps Up Manufacturing, Completes Validation of 15-Minute SARS-CoV-2 Antigen Test
ACS Publications
08/23/21
Blind Spot: A Braille Patterned Novel Multiplex Lateral Flow Immunoassay Sensor Array for the Detection of Biothreat Agents
Cision
09/04/20
Maxim Biomedical Inc. Rapid Antigen COVID-19 Test to Deliver Results in Less Than 15 Minutes While Reducing Risk of Exposure to Healthcare Workers